GlassScriptPrepare for your visit
Thomas C Spoor
Ophthalmology · Warren, MI · NPI 1982681086
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$7,024.90
in general payments reported to CMS, 2019-2025 · $45.15 in 2025
The $45.15 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Who reported paying
General payments only, top 6 by amount.
- Bausch & Lomb, A Division of Bausch Health US, LLC $6,250.00
- Ivantis, INC $142.86
- Abbvie INC. $141.76
- Merz Pharmaceuticals, LLC $129.53
- Merz North America, INC. $116.06
- Amgen INC. $91.46
Drugs and devices associated with these payments
Tepezza Botox Xeomin Qulipta
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Thomas Spoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/181024/thomas-c-spoor